Works matching DE "RIVASTIGMINE"
Results: 89
The transition from vivid dreams over floccillations and visual hallucinations to complete delirium in a geriatric patient at the dawn of Alzheimer's dementia: beneficial role of rivastigmine.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Rivastigmine patch for treatment of Alzheimer's disease in clinical practice in Thailand.
- Published in:
- Psychogeriatrics, 2013, v. 13, n. 1, p. 1, doi. 10.1111/j.1479-8301.2012.00403.x
- By:
- Publication type:
- Article
Safety and tolerability of rivastigmine transdermal patch formulation in newly diagnosed patients with Alzheimer's dementia in naturalistic conditions.
- Published in:
- Psychogeriatrics, 2012, v. 12, n. 3, p. 165, doi. 10.1111/j.1479-8301.2011.00400.x
- By:
- Publication type:
- Article
Directed Evolution and Immobilization of Lactobacillus brevis Alcohol Dehydrogenase for Chemo‐Enzymatic Synthesis of Rivastigmine.
- Published in:
- Chemistry - A European Journal, 2024, v. 30, n. 32, p. 1, doi. 10.1002/chem.202400454
- By:
- Publication type:
- Article
Atypical Presentation of Acetylcholinesterase Inhibitor-Induced Diarrhea in Older Adults with Cognitive Decline: An Aspect not to be Underestimated.
- Published in:
- Annals of Geriatric Medicine & Research, 2023, v. 27, n. 1, p. 83, doi. 10.4235/agmr.22.0116
- By:
- Publication type:
- Article
Cognitive effects with rivastigmine augmentation of risperidone: A 12-month, randomized, double-blind, placebo-controlled study in schizophrenia.
- Published in:
- Indian Journal of Psychiatry, 2017, v. 59, n. 2, p. 219, doi. 10.4103/psychiatry.IndianJPsychiatry_133_16
- By:
- Publication type:
- Article
Efficacy of rivastigmine transdermal therapy on low food intake in patients with Alzheimer's disease: The Attitude Towards Food Consumption in Alzheimer's Disease Patients Revive with Rivastigmine Effects study.
- Published in:
- Geriatrics & Gerontology International, 2019, v. 19, n. 7, p. 571, doi. 10.1111/ggi.13644
- By:
- Publication type:
- Article
Effect of rivastigmine on plasma butyrylcholine esterase activity and plasma ghrelin levels in patients with dementia in Alzheimer’s disease.
- Published in:
- Geriatrics & Gerontology International, 2018, v. 18, n. 6, p. 886, doi. 10.1111/ggi.13275
- By:
- Publication type:
- Article
Preliminary evidence that rivastigmine-induced inhibition of serum butyrylcholinesterase activity improves behavioral symptoms in Japanese patients with Alzheimer's disease.
- Published in:
- Geriatrics & Gerontology International, 2017, v. 17, n. 9, p. 1306, doi. 10.1111/ggi.12865
- By:
- Publication type:
- Article
Effects on agitation with rivastigmine patch monotherapy and combination therapy with memantine in mild to moderate Alzheimer's disease: a multicenter 24-week prospective randomized open-label study (the Korean EXelon Patch and combination with mEmantine Comparative Trial study)*
- Published in:
- Geriatrics & Gerontology International, 2017, v. 17, n. 3, p. 494, doi. 10.1111/ggi.12754
- By:
- Publication type:
- Article
Sinus arrest as a result of rivastigmine in an elderly dementia with Lewy bodies patient.
- Published in:
- Geriatrics & Gerontology International, 2015, v. 15, n. 2, p. 229, doi. 10.1111/ggi.12311
- By:
- Publication type:
- Article
Rivastigmine for ECT-induced cognitive adverse effects in late life depression (RECALL study): A multicenter, randomized, double blind, placebo-controlled, cross-over trial in patients with depression aged 55 years or older: Rationale, objectives and methods
- Published in:
- Frontiers in Psychiatry, 2022, v. 13, p. 1, doi. 10.3389/fpsyt.2022.953686
- By:
- Publication type:
- Article
Compliance with National and International Guidelines in the Treatment of Nonmotor Symptoms in Late-Stage Parkinson's Disease.
- Published in:
- Parkinson's Disease (20420080), 2023, p. 1, doi. 10.1155/2023/6667339
- By:
- Publication type:
- Article
Donepezil and Rivastigmine: Pharmacokinetic Profile and Brain-targeting After Intramuscular Administration in Rats.
- Published in:
- Iranian Journal of Pharmaceutical Research, 2020, v. 19, n. 3, p. 95, doi. 10.22037/ijpr.2019.1100723
- By:
- Publication type:
- Article
Characteristics of patients with Alzheimer's disease who switch to rivastigmine transdermal patches in routine clinical practice.
- Published in:
- Patient Preference & Adherence, 2013, v. 7, p. 47, doi. 10.2147/PPA.S38719
- By:
- Publication type:
- Article
Anti-dementia medication use in Aotearoa New Zealand: An exploratory study using health data from the Integrated Data Infrastructure (IDI).
- Published in:
- Australian & New Zealand Journal of Psychiatry, 2023, v. 57, n. 6, p. 895, doi. 10.1177/00048674221121091
- By:
- Publication type:
- Article
A very low dose of rivastigmine-induced Pisa syndrome in a clozapine-treated patient.
- Published in:
- Australian & New Zealand Journal of Psychiatry, 2018, v. 52, n. 2, p. 204, doi. 10.1177/0004867417741983
- By:
- Publication type:
- Article
Rivastigmine for treatment resistant Post Traumatic stress disorder.
- Published in:
- Australian & New Zealand Journal of Psychiatry, 2017, v. 51, n. 9, p. 946, doi. 10.1177/0004867417698234
- By:
- Publication type:
- Article
Piracetam, Rivastigmine and Their Joint Consumption Effects on MMSE Score Status in Patients with Alzheimer's Disease.
- Published in:
- Iranian Journal of Pharmacology & Therapeutics, 2012, v. 11, n. 2, p. 60
- By:
- Publication type:
- Article
Mitochondrial Effects of Hydromethylthionine, Rivastigmine and Memantine in Tau-Transgenic Mice.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 13, p. 10810, doi. 10.3390/ijms241310810
- By:
- Publication type:
- Article
Hypoxic and Hypercapnic Responses in Transgenic Murine Model of Alzheimer's Disease Overexpressing Human AβPP: The Effects of Pretreatment with Memantine and Rivastigmine.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 11, p. 6004, doi. 10.3390/ijms23116004
- By:
- Publication type:
- Article
Donepezil as a safe alternative treatment after maculo‐papular eruption related to rivastigmine in Lewy body disease: a case report and pharmacovigilance data.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Rivastigmine ameliorates indomethacin experimentally induced gastric mucosal injury via activating α7nAChR with inhibiting oxidative stress and apoptosis.
- Published in:
- Journal of Biochemical & Molecular Toxicology, 2022, v. 36, n. 10, p. 1, doi. 10.1002/jbt.23147
- By:
- Publication type:
- Article
The effects of rivastigmine on neuropsychiatric symptoms in the early stages of Parkinson's disease: A systematic review.
- Published in:
- European Journal of Neurology, 2024, v. 31, n. 2, p. 1, doi. 10.1111/ene.16142
- By:
- Publication type:
- Article
Validated LC/MS/MS Method for the Determination of Rivastigmine in Human Plasma: Application to a Pharmacokinetic Study in Egyptian Volunteers to Determine the Effect of Gender and Body Mass Index.
- Published in:
- Journal of Chromatographic Science, 2023, v. 61, n. 5, p. 453, doi. 10.1093/chromsci/bmac046
- By:
- Publication type:
- Article
The Effect of the Acetylcholinesterase Inhibitor Rivastigmine on the Pentylenetetrazole-Induced Kindling Model of Experimental Epilepsy.
- Published in:
- Acta Physiologica, 2023, v. 237, p. 65
- By:
- Publication type:
- Article
The Effect of Rivastigmine on Spike-Wave Discharges and Interaction with T-Type Calcium Channels in WAG/Rij Rats.
- Published in:
- Acta Physiologica, 2023, v. 237, p. 34
- By:
- Publication type:
- Article
Carbamate as a potential anti‐Alzheimer's pharmacophore: A review.
- Published in:
- Drug Development Research, 2023, v. 84, n. 8, p. 1624, doi. 10.1002/ddr.22113
- By:
- Publication type:
- Article
Novel Rivastigmine Derivatives as Promising Multi-Target Compounds for Potential Treatment of Alzheimer's Disease.
- Published in:
- Biomedicines, 2022, v. 10, n. 7, p. N.PAG, doi. 10.3390/biomedicines10071510
- By:
- Publication type:
- Article
HMTM-Mediated Enhancement of Brain Bioenergetics in a Mouse Tauopathy Model Is Blocked by Chronic Administration of Rivastigmine.
- Published in:
- Biomedicines, 2022, v. 10, n. 4, p. 867, doi. 10.3390/biomedicines10040867
- By:
- Publication type:
- Article
Development and Characterization of Rivastigmine Hydrogen Tartrate Elementary Osmotic Tablets.
- Published in:
- International Journal of Pharmaceutical Investigation, 2024, v. 14, n. 1, p. 239, doi. 10.5530/ijpi.14.1.30
- By:
- Publication type:
- Article
Analytical Method Development and Validation of Rivastigmine in its Pure and Pharmaceutical Dosage form Using UPLC.
- Published in:
- International Journal of Pharmaceutical Investigation, 2023, v. 13, n. 3, p. 595, doi. 10.5530/ijpi.13.3.074
- By:
- Publication type:
- Article
Determination of Alzheimer's Drugs in a Human Urine Sample by Different Chemometric Methods: Chemometric Determination of Alzheimer's Drugs.
- Published in:
- International Journal of Analytical Chemistry, 2024, v. 2024, p. 1, doi. 10.1155/2024/5535816
- By:
- Publication type:
- Article
Effect of Rivastigmine (Acetyl Cholinesterase Inhibitor) versus Placebo on Manic Episodes in Patients with Bipolar Disorders: Results from a Double Blind, Randomized, Placebo-Controlled Clinical Trial.
- Published in:
- Neuropsychobiology, 2019, v. 78, n. 4, p. 200, doi. 10.1159/000501210
- By:
- Publication type:
- Article
No interaction between rivastigmine and citalopram on memory and novelty processing in healthy human volunteers.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The ReSPonD trial - rivastigmine to stabilise gait in Parkinson's disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson's disease who have fallen.
- Published in:
- BMC Neurology, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2377-13-188
- By:
- Publication type:
- Article
The ReSPonD trial--rivastigmine to stabilise gait in Parkinson's disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson's disease who have fallen.
- Published in:
- 2013
- By:
- Publication type:
- journal article
The Impact of a Long-Term Rivastigmine and Donepezil Treatment on All-Cause Mortality in Patients With Alzheimer’s Disease.
- Published in:
- American Journal of Alzheimer's Disease & Other Dementias, 2018, v. 33, n. 6, p. 385, doi. 10.1177/1533317518775044
- By:
- Publication type:
- Article
Which Rivastigmine Formula is Better for Heart in Elderly Patients With Alzheimer’s Disease: Oral or Patch?
- Published in:
- American Journal of Alzheimer's Disease & Other Dementias, 2014, v. 29, n. 8, p. 735, doi. 10.1177/1533317514536598
- By:
- Publication type:
- Article
Efficacy of Higher Dose 13.3 mg/24 h Rivastigmine Patch on Instrumental Activities of Daily Living in Patients with Mild-to-Moderate Alzheimer's Disease.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
New 1,2,4-oxadiazole derivatives as potential multifunctional agents for the treatment of Alzheimer's disease: design, synthesis, and biological evaluation.
- Published in:
- BMC Chemistry, 2024, v. 18, n. 1, p. 1, doi. 10.1186/s13065-024-01235-x
- By:
- Publication type:
- Article
Rivastigmine Regulates the HIF-1α/VEGF Signaling Pathway to Induce Angiogenesis and Improves the Survival of Random Flaps in Rats.
- Published in:
- Frontiers in Pharmacology, 2022, v. 12, p. 1, doi. 10.3389/fphar.2021.818907
- By:
- Publication type:
- Article
Formulation and Evaluation of Eudragit RL-100 Nanoparticles Loaded In-Situ Forming Gel for Intranasal Delivery of Rivastigmine.
- Published in:
- Advanced Pharmaceutical Bulletin, 2020, v. 10, n. 1, p. 20, doi. 10.15171/apb.2020.003
- By:
- Publication type:
- Article
Histological Study on the Effect of Rivastigmine and Coconut Oil on the Hippocampus of Experimentally Induced Alzheimer's Disease in Adult Male Albino Rats.
- Published in:
- Egyptian Journal of Histology, 2023, v. 46, n. 2, p. 723, doi. 10.21608/ejh.2022.114519.1628
- By:
- Publication type:
- Article
Rivastigmine for treatment-refractory posttraumatic stress disorder: a systematic review.
- Published in:
- East Asian Archives of Psychiatry, 2024, v. 34, n. 2, p. 29, doi. 10.12809/eaap2353
- By:
- Publication type:
- Article
ISMP Adverse Drug Reactions: Adalimumab-Induced Aseptic Meningitis Pill Desiccant -Induced Acute Hypoxic Respiratory Failure Rivastigmine Patch -Induced Angioedema Acute Liver Failure Due to Etodolac Severe Cognitive Impairment Due to High Free Valproic Acid Levels
- Published in:
- Hospital Pharmacy, 2018, v. 53, n. 5, p. 292, doi. 10.1177/0018578718794518
- By:
- Publication type:
- Article
Safety and efficacy of acetylcholinesterase inhibitors for Alzheimer's disease: A systematic review and meta-analysis.
- Published in:
- Advances in Clinical & Experimental Medicine, 2024, v. 33, n. 11, p. 1179, doi. 10.17219/acem/176051
- By:
- Publication type:
- Article
Diphenhydramine-Induced Antimuscarinic Delirium Treated with Physostigmine and Transdermal Rivastigmine.
- Published in:
- Journal of Medical Toxicology, 2023, v. 19, n. 2, p. 219, doi. 10.1007/s13181-022-00925-z
- By:
- Publication type:
- Article
Rivastigmine for Cognitive Impairment in Multiple Sclerosis: A Prospective Randomized Open Label Study with Blinded End‑Point Assessment.
- Published in:
- Neurology India, 2023, v. 71, n. 3, p. 514, doi. 10.4103/0028-3886.378694
- By:
- Publication type:
- Article
A Novel Formulation: Donepezil Patch.
- Published in:
- Senior Care Pharmacist, 2023, v. 38, n. 7, p. 300, doi. 10.4140/TCP.n.2023.300
- By:
- Publication type:
- Article